Cleveland Clinic Risk Calculator Library

Department of Quantitative Health Sciences

Back to Top

BENIGN PROSTATIC HYPERPLASIA


For Patients Receiving Dutasteride Therapy

Predicts probability of acute urinary retention or surgical intervention within 2 years.

BLADDER CANCER


For Patients Immediately Following Radical Cystectomy

Predicts 5-year progression-free probability.

BRAIN CANCER


For Patients Diagnosed with Brain Metastasis

Predicts 6-month, 12-month and median survival.


For Patients with Newly Diagnosed Glioblastoma

Predicts 6-, 12- and 24-month survival probability.

BREAST CANCER


For Women with Positive Sentinel Node Biopsy

Predicts risk of additional node metastasis following complete axillary lymph node dissection.

COLORECTAL CANCER


For Patients After Live Resection For Stage IV Colorectal Cancer

Predicts 96-month disease-specific survival.


For Patients Immediately Following Surgery

Predicts the 5- and 10-year recurrence-free survival percentage.

EPILEPSY


For Patients Eligible For Epilepsy Surgery

Predicts 2-year and 5-year probabilities of freedom from seizure recurrence and probabilities of obtaining an Engel Score of 1.

FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY


For Women with Urinary Incontinence Considering Midurethral Sling Surgery

Predicts risk of any adverse event, bothersome stress, urge incontinence or positive stress test with 12 months of surgery.


For Women Considering Surgery for Pelvic Organ Prolapse

Predicts risk of urinary incontinence to help identify patients who may benefit from more aggressive management.


For Women about to Deliver Their First Baby and Immediately Following Delivery

Predicts postpartum urinary and fecal incontinence.


For Women Considering Gynecologic Surgery

Predicts 30-day transfusion probability.

GASTRIC CANCER


For Patients Considering R0 Resection for Gastric Carcinoma

Predicts 5- and 9-year disease-specific survival.

HEART DISEASE


For Acute Coronary Syndrome Patients Recently Discharged

Predicts 30-day and 1-year risks of mortality, myocardial infarction, or revascularization.


For Patients Hospitalized with ACS Receiving PCI Treatment

Predicts the probability of cerebrovascular accidents using patient demographics and clinical characteristics.


For Patients about to Undergo Transvenous Lead Extraction

Predicts 30-day all-cause mortality.


For Patients with Suspected Coronary Artery Disease and a Normal Electrocardiogram

Predicts 3-, 5- and 10-year survival after exercise treadmill testing.

INFERTILITY


For Infertile Men about to Undergo Varicocele Repair

Predicts changes in semen parameters.

CHRONIC KIDNEY DISEASE


For Patients Considering Living Donor Renal Transplant

Predicts the 5-year graft survival and 1-year eGFR value.

KIDNEY CANCER


For Patients Immediately Following Partial or Radical Nephrectomy

Predicts 5- and 7-year freedom from recurrence and 7-year renal insufficiency.


For Patients With Metastatic Renal Cell Carcinoma

Predicts 12-month progression-free survival with sunitinib or pazopanib.


For Patients with Small Renal Masses

Predicts the probability of malignant pathology for small renal masses.

LIVER DISEASE


For Patients Prior to Orthotopic Liver Transplantation

Predicts the need of a patient to attend an extended care facility (ECF).


For Children with Non-Alcoholic Fatty Liver Disease

Predicts NAFLD histological score.

MELANOMA


For Patients Immediately Prior to Sentinel Lymph Nodes Biopsy

Predicts the probability of positive sentinel nodes.

OBESITY


For Patients Immediately Following Bariatric Surgery

Predicts 30-day probability of venous thromboembolisms(VTEs) post discharge.


For Patients Immediately Following Laparoscopic Sleeve Gastrectomy

Estimates the probability of presence of a serious adverse events.

ORAL CANCER


For Patients after Surgery Oral Cavity Squamous Cell Carcinoma

Predicts 5-year percentage of recurrence-free survival to assist in determining the need for adjuvant treatment.

OVARIAN CANCER


For Patients after Primary Surgery for Bulky Stage IIIC Carcinoma

Predicts 5-year probability of survival.

PANCREATIC CANCER


For Patients after Resection for Adenocarcinoma of the Pancreas

Predicts 12-, 24- and 36-month survival.

PENILE CANCER


For Patients Undergone Surgery for Squamous Cell Carcinoma of the Penis

Predict 5-year cancer specific survival and lymph node involvement.

PROSTATE CANCER 1, RISK PRIOR TO DIAGNOSIS


For Patients Prior to Initial Biopsy

Predicts percentage chance of having prostate cancer and of having high grade prostate cancer to help determine treatment options.


For Patients with a Prior Negative 6- to 12-Core Biopsy in the past 6 months

Determines 4-year probability of outcomes with or without dutasteride.


For Patients with Prior Negative Biopsy

Predicts percentage of having prostate cancer with repeated prostate biopsy.

PROSTATE CANCER 2, PRE-TREATMENT


For Patients Immediately Prior to Surgery

Predicts the probability of upgrading the Gleason score in patients with low- and intermediate-grade prostate cancer on biopsy to help identify patients who may benefit from more aggressive or novel therapy.


For Patients Recently Diagnosed with Clinically Localized Prostate Cancer

Predicts 5- and 10-year probabilities for radical prostatectomy, watchful waiting, and 3-dimensional conformal radiation therapy of survival, indolent cancer, freedom from recurrence, metastasis and trifecta.

PROSTATE CANCER 3, POST-TREATMENT


For Patients Immediately Following Radical Prostatectomy

Predicts 7-, 9- and 10-year post-treatment freedom from recurrence, and 10- and 15-year cancer-specific mortality.


For Patients Immediately Following Brachytherapy

Predicts 7- and 9-year post-treatment freedom from recurrence.

PROSTATE CANCER 4, PSA RECURRENCE FOLLOWING RADICAL PROSTATECTOMY


For Patients with Biochemical Recurrence Following Radical Prostatectomy

Predicts the probability of freedom from biochemical failure at 5- and 10-year and cumulative incidence of metastasis at 5- and 10-year for men receiving salvage radiation therapy.


For Patients with Biochemical Recurrence Following Radical Prostatectomy

Predicts 5-, 10- and 15-year prostate cancer-specific mortality.

PROSTATE CANCER 5, METASTATIC DISEASE


For Men with Progressive Metastatic Disease

Predicts 1- and 2-year overall survival.

PSYCHOSIS


For Youth at High Risk

Predicts the conversion to psychosis for youth who are at high risk due to symptoms, genetic risk, and recent decline in functioning based on a variety of tests and psychometric dimensions.

SARCOMA


For Patients Considering Treatment for Primary Soft Tissue Sarcoma

Predicts postoperative rates of 12-year sarcoma-specific mortality.


For Patients with Sarcoma

Predicts 1-, 2- and 3-year risk of sarcoma-specific death following local recurrence.

SMALL BOWEL DISEASE


For Patients Considering Organ Space Surgical Site Infection

Predicts 30-day infection risk of organ space surgical site infection.

SPINE SURGERY


For Patients Eligible for Cervical Spine Surgery

Predicts probability of emergency department visit within 30 days, readmission within 30 days and reoperation for infection within 90 days. Predicts change in EQ-5D, PHQ-9 and PDQ quality-of-life metrics.

THYROID CANCER


For Patients with Thyroid Nodules

Predicts probability of thyroid cancer in thyroid nodules.

TOTAL JOINT DETERIORATION


For Patients Immediately after Total Joint Arthroplasty

Predicts length of stay and chance of NOT returning home.

TYPE 2 DIABETES


For Patients with Type 2 Diabetes

Predicts 6-year mortality.